Sophia Genetics has been granted a patent for a computer-implemented method to analyze next-generation sequencing genomic data from sourcing laboratories. The method involves receiving sequencing data, identifying characteristics, aligning data to a genomic sequence, refining alignment data, and identifying genomic variants. GlobalData’s report on Sophia Genetics gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
According to GlobalData’s company profile on Sophia Genetics, AI-assisted genome sequencing was a key innovation area identified from patents. Sophia Genetics's grant share as of April 2024 was 18%. Grant share is based on the ratio of number of grants to total number of patents.
Genomic data analyzer system for next generation sequencing data
A recently granted patent (Publication Number: US11923049B2) discloses a computer-implemented method for analyzing next-generation sequencing genomic data from sourcing laboratories. The method involves receiving a sequencing analysis request, identifying characteristics associated with the request, configuring a data alignment module to align raw sequencing data, refining the alignment data, and identifying genomic variants. The method also includes reporting the identified variants back to the sourcing laboratory. Additionally, the patent covers the identification of various characteristics such as laboratory identification metadata, genomic context identifiers, and variant calling refinement identifiers to enhance the accuracy of the analysis.
Furthermore, the patent extends to analyzing genomic data from multiple sourcing laboratories, where each laboratory's sequencing request is processed individually. The method involves aligning the input sequencing data to a genomic sequence, identifying variants associated with the data, and updating a laboratory information database with relevant identifiers. The patent also includes provisions for appending and updating the database with new laboratory information upon registration or updates. Overall, the patented method aims to streamline the analysis of next-generation sequencing data by efficiently aligning raw data, refining alignment data, and accurately identifying genomic variants, ultimately enhancing the overall sequencing analysis process for sourcing laboratories.
To know more about GlobalData’s detailed insights on Sophia Genetics, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
